Skip to main content

Table 1 Baseline demographics and clinical characteristics of patients with PD-associated peritonitis

From: Comparison of clinical outcomes between culture-negative and positive peritonitis in patients undergoing maintenance peritoneal dialysis: a prospective cohort study

Variable

Total

(N = 81)

CNP

(N = 35)

CPP

(N = 46)

p-value

Age, years

59 (43–69)

55 (41–68)

63 (50–69)

0.102

Female, N (%)

45 (55.6)

25 (71.4)

20 (43.5)

0.022

DM (%)

46 (56.8)

20 (57.1)

26 (56.5)

1.000

Duration of PD, year

1.3 (0.7–3.0)

1.7 (0.8–3.5)

1.2 (0.6–2.7)

0.233

BMI, kg/m2

24 (21.9–27.3)

24.0 (21.7–27.3)

24.0 (22.1–27.3)

0.905

Renal diagnosis, N (%)

Glomerulonephritis

6 (7.4)

4 (11.4)

2 (4.3)

0.396

DM

30 (37.0)

15 (42.9)

15 (32.6)

HT

29 (35.8)

12 (34.3)

17 (37.0)

ADPKD

5 (6.2)

2 (5.7)

3 (6.5)

Obstructive uropathy

8 (9.9)

1 (2.9)

7 (15.2)

Others

3 (3.7)

1 (2.9)

2 (4.3)

PD performed by caregiver (%)

43 (53.1)

18 (51.4)

25 (55.6)

0.971

CAPD, N (%)

77 (95.1)

34 (97.1)

43 (93.5)

0.831

BUN, mg/dL

36.0 (27.0–52.0)

37.0 (26.8–50.5)

34.0 (27.0–52.0)

0.834

Creatinine, mg/dL

8.0 (5.5–11.6)

7.3 (5.2–10.7)

8.1 (5.6–13.7)

0.259

Potassium, mEq/L

3.4 (3.0–3.8)

3.3 (3.0–3.7)

3.52 (3.0–4.2)

0.227

Hemoglobin, g/dL

10.0 (8.1–11.0)

10.0 (8.7–11.5)

10.0 (7.8–10.8)

0.669

Albumin, g/dL

2.7 (1.8–3.0)

2.7 (1.8–3.0)

2.6 (1.9–3.0)

0.879

PDF WBC, ×1000/µL

2.8 (1.1–8.2)

2.5 (0.6–3.9)

3.5 (1.3–11.0)

0.024

%PMN

91 (84–95)

90 (78–95)

91 (85–95)

0.307

  1. PD: peritoneal dialysis, CNP: culture-negative peritonitis, CPP: culture-positive peritonitis, DM: diabetes mellitus, BMI: body mass index, HT: hypertension, ADPKD: autosomal dominant polycystic kidney disease, CAPD: continuous ambulatory peritoneal dialysis, BUN: blood urea nitrogen, PDF: peritoneal dialysis fluid, WBC: white blood cell, PMN: polymorphonuclear
  2. Continuous variables are reported as median (IQR) for non-normally distributed variables